More CREDENCE for SGLT2 Inhibition

被引：14
|
作者：
Verma, Subodh [1 ]
Bhatt, Deepak L. [2 ]
机构：
[1] Univ Toronto, St Michaels Hosp, Div Cardiac Surg, 8th Floor,Bond Wing,30 Bond St, Toronto, ON M5B 1W8, Canada
[2] Harvard Med Sch, Brigham & Womens Hosp, Heart & Vasc Ctr, Boston, MA 02115 USA
来源：
CIRCULATION | 2019年 / 140卷 / 18期
关键词：
cardiovascular diseases; diabetes mellitus; diabetic nephropathies; kidney failure; chronic;
D O I：
10.1161/CIRCULATIONAHA.119.041181
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1448 / 1450
页数：3
相关论文
共 50 条
  • [41] Role of Glycosuria in SGLT2 Inhibitor-Induced Cardiorenal Protection: A Mechanistic Analysis of the CREDENCE Trial
    Ferrannini, Ele
    Solini, Anna
    Baldi, Simona
    Scozzaro, Tiziana
    Polidori, David
    Natali, Andrea
    Hansen, Michael K.
    DIABETES, 2024, 73 (02) : 250 - 259
  • [42] The Pathophysiological Basis of Diabetic Kidney Protection by Inhibition of SGLT2 and SGLT1
    Oe, Yuji
    Vallon, Volker
    KIDNEY AND DIALYSIS, 2022, 2 (02): : 349 - 368
  • [43] Sweet relationship between SGLT2 inhibition and heart failure
    Nabeshima, Yosuke
    Tanaka, Atsushi
    Node, Koichi
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2024, 410
  • [44] SGLT2 inhibition to address the unmet needs in diabetic nephropathy
    Barutta, Federica
    Bernardi, Sara
    Gargiulo, Giuseppe
    Durazzo, Marilena
    Gruden, Gabriella
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2019, 35 (07)
  • [45] Softening the Stiff Heart SGLT2 Inhibition and Diastolic Function
    Connelly, Kim
    Cai, Sean
    JACC-CARDIOVASCULAR IMAGING, 2021, 14 (02) : 408 - 410
  • [46] REAL WORLD OUTCOMES OF SGLT2 INHIBITION IN A HFREF POPULATION
    Savage, Patrick
    McElhatton, Daniel
    Campbell, Michael
    Bamford, Jordan
    Reid, Rebecca
    Dixon, Lana
    HEART, 2022, 108 : A92 - A93
  • [47] SGLT2 INHIBITION PREVENTS RENAL FIBROSIS IN CYCLOSPORINE NEPHROPATHY
    Castoldi, Giovanna
    Carletti, Raffaella
    Ippolito, Silvia
    Colzani, Massimiliano
    Barzaghi, Francesca
    Stella, Andrea
    Zerbini, Gianpaolo
    Perseghin, Gianluca
    Zatti, Giovanni
    Di Gioia, Cira
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1307 - 1307
  • [48] SGLT2 inhibition: efficacy and safety in type 2 diabetes treatment
    Scheen, Andre J.
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (12) : 1879 - 1904
  • [49] Impact of SGLT2 inhibition on glucosuria in MODY3
    Maagensen, H.
    Jensen, J. S.
    Hoyerup, S. O.
    Thuesen, A. C. B.
    Krogh, J.
    Rossing, P.
    Hansen, T.
    Knop, F. K.
    Haedersdal, S.
    Vilsboll, T.
    DIABETOLOGIA, 2024, 67 : S120 - S121
  • [50] Mechanistic effects of SGLT2 inhibition on blood pressure in diabetes
    Yaribeygi, Habib
    Atkin, Stephen L.
    Sahebkar, Amirhossein
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (02) : 1679 - 1683
12345